Results 71 to 80 of about 59,410 (231)

A Rare Case Report of Localized Bullous Fixed Drug Eruption Due to Tamsulosin

open access: yesJK Science, 2023
Fixed drug eruption is a cutaneous adverse reaction to a specific drug. Tamsulosin is an alpha-1 adrenergic receptor blocker used to treat benign prostatic hyperplasia in men.
Sheba Mariam Jacob   +3 more
doaj  

Multifocal fixed drug eruption with COX-2 inhibitor-celecoxib

open access: yesIndian Journal of Dermatology, 2013
Cyclooxygenase-2 (COX-2) inhibitors are rapidly becoming the first choice nonsteroidal anti-inflammatory drugs (NSAIDs) for various rheumatological and other painful conditions.
Shikha Chugh   +4 more
doaj   +1 more source

AN URBAN MARKETPLACE UNDER PRESSURE: The Steady Gentrification Process of Porta Palazzo (Turin) Through the Eyes of Market Sellers and Policy Makers

open access: yesInternational Journal of Urban and Regional Research, EarlyView.
Abstract Marketplaces, crucial sites for low‐income populations as sources of affordable goods and social interaction, are at a critical juncture. They are experiencing decline due to the rise of shopping centres and neglect by public authorities, while at the same time being rediscovered as tourist attractions, sources of profit and tools for urban ...
Francesca Ru
wiley   +1 more source

Fixed Drug Eruption in an Epileptic Patient Previously Receiving Treatment With Phenytoin for Seven Years

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2013
A 52-year-old African American female presented with severe left thigh pain of unknown etiology. She had a past medical history of generalized seizure disorder treated with phenytoin for 7 years without incident.
Keaton S. Smetana   +2 more
doaj   +1 more source

Interactional privilege of violence: Status and interaction in the street field

open access: yesCriminology, EarlyView.
Abstract Criminologists have long described and theorized the relationship between status, respect, and violence within urban communities. Although this finding is generally accepted within criminology, ethnographic empirical illustrations of this phenomenon are sparse.
Hakan Kalkan, Heith Copes
wiley   +1 more source

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Fixed Drug Eruption due to Achiote Dye

open access: yesCase Reports in Dermatology, 2016
Fixed drug eruption (FDE) is a localized type IV sensitivity reaction to a systemically introduced allergen. It usually occurs as a result of new medication, making identification and avoidance of the trigger medication straightforward; however, in a ...
Ian Tattersall, Bobby Y. Reddy
doaj   +1 more source

Management of Treatment Resistant EGFR Inhibitor‐Induced Papulopustular Exanthema With Isotretinoin and Dapsone

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Epidermal growth factor receptor inhibitors (EGFRi) commonly cause papulopustular exanthemas that may compromise the success of cancer therapy. While tetracyclines are first‐line treatment, data on alternative systemic agents for refractory cases remain limited.
Ishana Dixit   +2 more
wiley   +1 more source

The Harmful Trifecta of Skincare in African and Asian Populations: Triple Action Creams, Skin‐Lightening Creams, and Antiseptic Soaps

open access: yes
JEADV Clinical Practice, EarlyView.
Olufolakemi Cole‐Adeife   +4 more
wiley   +1 more source

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy